Results 181 to 190 of about 1,518 (207)

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

New England Journal of Medicine, 2020
Robert Zeiser, Nikolas von Bubnoff, Jason Butler   +2 more
exaly  

Ruxolitinib cream (Opzelura) for nonsegmental vitiligo.

The Medical letter on drugs and therapeutics, 2022
openaire   +1 more source

Ruxolitinib Cream Ameliorates Itch and Inflammation in Preclinical Models of Dermatitis

Journal of Allergy and Clinical Immunology, 2021
Monika Scuron, Brittany Fay, Andrew Connell, Michael Peel, Paul Smith   +4 more
openaire   +1 more source

Ruxolitinib cream rapidly decreases skin pain in atopic dermatitis

Journal of Investigative Dermatology, 2021
Blauvelt, A., Papp, K., Simpson, E., Silverberg, J.I., Kim, B.S., Kwatra, S.G., Kuligowski, M.E., Venturanza, M.E., Sun, K., Kircik, L.   +9 more
openaire   +1 more source

A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

New England Journal of Medicine, 2012
Ruben Mesa, Jason Gotlib, Vikas Gupta
exaly  

JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis

New England Journal of Medicine, 2012
Claire N Harrison, Jean-Jacques Kiladjian, Haifa Kathrin Al-ali   +2 more
exaly  

Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

New England Journal of Medicine, 2015
Alessandro Maria Vannucchi, Martin Griesshammer, Tamas Masszi   +2 more
exaly  

Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia

Journal of Clinical Oncology, 2020
Stephen T Oh, Michael Joseph Cascio, Jeffrey W Tyner   +2 more
exaly  

The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation

Leukemia, 2020
Felicitas La Rosée, Sebastian Birndt, Paul La Rosée   +2 more
exaly  

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

Leukemia, 2015
Robert Zeiser, Claudia Lengerke, Il-Kang Na   +2 more
exaly